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Adenosine is a purine nucleoside pivotal for homeostasis in cells and tissues. Stimulation of the aden-
osine receptors (AR) has been shown to regulate the nuclear orphan receptor 4A (NR4A1-3) family,
resulting in attenuation of hyper-inflammatory responses in myeloid cells. The NR4A1-3 orphan re-
ceptors are early immediate response genes and transcriptional regulators of cell and tissue homeostasis.
The signal transduction and transcriptional mechanism(s) of how AR-stimulation promotes NR4A
expression in myeloid cells is unknown and is the focus of this study. We confirm that adenosine and the
stable analogue, 50-N-Ethylcarboxamidoadenosine (NECA), enhance NR4A1-3 expression in THP-1 cells.
Pharmacological approaches identified that protein kinase D (PKD) mediates AR-stimulated NR4A
expression in myeloid cells and reveals no involvement of PKA nor PKC. The role of NF-kB, a principal
regulator of NR4A expression in myeloid cells, was examined as a possible transcriptional regulator
downstream of PKD. Utilising BAY11-7082 and MG-132, inhibitors of the respective ubiquitin and pro-
teasome pathways essential for NF-kB activation, suggested a prospective role for NF-kB, or more spe-
cifically signalling via IKKa/b. However, biological interventional studies using overexpression of IkBa in
myeloid cells and MEF cells lacking IKKa and IKKb (IKKa/b/-) revealed the NF-kB pathway is not utilised
in mediating AR-stimulated NR4A expression. Thus, this study contributes mechanistic insight into how
AR signalling modulates the expression of NR4A receptors, pivotal regulators of inflammatory responses
in myeloid cells.
© 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The purine nucleoside, adenosine, plays multiple roles in
physiological and pathological disease states [1]. Once accumu-
lated, adenosine binds with varied affinities to one of four target G-
protein coupled adenosine receptors (AR): A1, A2a, A2b and A3.
When stimulated they then act through secondary intracellular
messenger systems including cAMP and calcium [1]. The down-
stream kinases identified as being important for carrying out thee Foundation Ireland’s (SFI)
ell as the European Regional
ernal grants.
cine, University College Dub-
r Inc. This is an open access articlfunctions of adenosine are primarily protein kinase A (PKA) and
protein kinase C (PKC), along with some studies demonstrating a
role for protein kinase D (PKD) [2]. Finally, beyond kinase activa-
tion, adenosine has non-genomic and genomic effects, such as
regulating ion transport directly or regulating major transcription
factors such as CREB and NF-kB [1,3,4].
The nuclear receptor family 4A (NR4A) receptors have emerged
over the past decade as pivotal regulators of inflammatory re-
sponses [5]. Two of the main transcriptional regulators upstream of
NR4A receptor activation are CREB and NF-kB [5e7]. AR stimulation
has been shown to enhance the expression of all three NR4A family
members [8e13]. Studies have uncovered the roles of PKA, PKC,
PKD, MAPK/ERK, CREB and NF-kB in mediating stimulus- and cell-
specific NR4A regulation [5e7,14e17]. However, few studies have
examined the signalling molecules/pathways following AR-
stimulation. Therefore, within this study we examined the factorse under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. Adenosine receptor stimulation enhances NR4A expression in THP-1 cells. (a, b) THP-1 cells were exposed to adenosine (ADO) (1, 10 and 50 mM) (n ¼ 3) (a) and NECA
(20 mM) (n ¼ 5) (b) for 2 hs followed by RNA isolation. Analysis: (a, b) Following RNA isolation, qRT-PCR was performed for NR4A1-3 and the housekeeping gene GAPDH. For
statistical analysis of qRT-PCR experiments, a one-way ANOVA with a Tukeys post-hoc test was used. *p < 0.05, ***p < 0.001 treatments compared to untreated control (Un).
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and transcriptional levels in myeloid cell line THP-1.
Here, we showed that concentration-dependent adenosine and
50-N-Ethylcarboxamidoadenosine (NECA), a stable adenosine
analogue, control of NR4A1-3 expression in THP-1 cells. Following
this, we investigated for the first time which protein kinase was
involved downstream of AR stimulation in myeloid cells. Pharma-
cological approaches reveal that PKD, and not PKA or PKC, is the
kinase involved in AR-driven NR4A1-3 expression in monocytes.
We then assessed if a major NR4A regulator in myeloid cells, NF-kB,
was involved in AR-driven NR4A expression. Using a combination
of pharmacological and biological interventions we provide evi-
dence that while NF-kB is not involved in AR-driven NR4A
expression, ubiquitin and proteasome pathways are involved in AR-
mediated control. Thus, this study contributes mechanistic insight
into howAR signallingmodulates the expression of NR4A receptors,
pivotal regulators of inflammatory responses in myeloid cells.2. Methods
2.1. Cell culture
Human monocyte THP-1 cells were obtained from American
type culture collection (ATCC® TIB-202™) and were cultured in
RPMI-1640eGlutaMax™ media (Life Technologies™). Mouse20embryonic fibroblast cells lacking IKKa and IKKb (Ikka/b/-) and
their wild-type controls (WT) were a generous gift from Dr Inder
Verma (Salk Institute, La Jolla, CA). All media was supplemented
with 10% (v/v) FBS, 100 U/ml penicillin, 100 mg/ml streptomycin,
and 100 mg/ml streptomycin. All cells were cultured at 21% O2, 5%
CO2 and maintained in a humidified tissue culture incubator at
37 C, balanced with nitrogen. Reagents/chemicals used
throughout experiments were adenosine (Sigma-Aldrich,#A9251-
1G), NECA (Tocris Bioscience,#1691), BAY11-7082 (Sigma-
Aldrich,#BM5556-10 MG), MG-132 (Enzo Life Sciences,#BML-
P1102-0005), H-89 (Santa Cruz Biotechnology,#sc-3537), GO6983
(Tocris Bioscience,#2285), phorbol myristate acetate (PMA) (Sant
Cruz Biotechnology,#sc-3576), CID-755673 (Sigma-Aldrich,
#SML003-5MG) Lipopolysaccharide (LPS) (Sigma-Aldrich, #L6529-
1 MG).2.2. Real-time quantitative reverse transcription PCR (qRT-PCR)
RNA extraction, cDNA synthesis and qRT-PCRwere performed as
previously described [8]. Primer sequences used are detailed in
Supplemental Table 1.2.3. Western blotting
Whole cell lysis, andwestern blotting forNR4A2 (PPeN1404-00)
Fig. 2. Adenosine upregulation of NR4A’s in THP-1 cells does requires protein kinase D. (a) THP-1 cells were exposed to NECA (20 mM) for 2.5 hs alone, H-89 dihydrochloride
(100 nM) for 2.5hs alone or NECA (20 mM) for 2 hs following a 30 min pre-treatment with H-89 dihydrochloride (100 nM) followed by RNA isolation (n ¼ 5). (b) THP-1 cells were
exposed to NECA (20 mM), GO6893 (100 nM) and PMA (32 nM) (EC50 or Ki) for 2.5 hs alone or NECA (20 mM) for 2 hs following 30 min pre-treatment with GO6893 (100 nM) or PMA
(32 nM) followed by RNA isolation (n ¼ 3). (c) THP-1 cells were exposed to NECA (20 mM) for 2.5 hs alone and for 2 h after a 30 min pre-treatment with CID 755673 (83 and 166 nM),
followed by RNA isolation (n ¼ 4). Analysis: (a,b,c) Following RNA isolation, qRT-PCR was performed for targets genes NR4A1-3 and housekeeping gene GAPDH. For statistical
analysis of qRT-PCR experiments, a one-way ANOVA with a Tukeys post-hoc test was used. *p < 0.05, **p < 0.01, ***p < 0.001, treatments compared to untreated control (Un).
NS¼Not significant. Comparison between treatments is shown using a bar attachment.
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was performed as previously described [8].
2.4. Transient transfection of THP-1 cells
THP-1 cells were transiently transfected with IkBa over-
expression constructs and plasmid backbone controls using the
TransIT-X2® (Madison WI, USA) protocol as per manufacturer’s
instructions. Briefly, transient transfections were performed in 12
well plates with 500,000 cells in each well in 900 mL of cell culture
media. Amastermixwas then prepared for the IkappaBalpha (IkBa)
plasmid (pIkBa-EGFP) and backbone control plasmid (EGFP, Clon-
tech) consisting of Optimem:TransIT-X2:plasmid (100 ml:3 ml:1 mg),
reagents mixed and allowed to stand for 20 min followed by
addition to the cells. pIkBa-EGFP was a gift from Prof. Michael
White [18].
2.5. Data presentation and statistical analysis
All data are presented as fold over control (FOC)± standard error
of the mean (±SEM) (minimum n ¼ 3 independent biological21replicates), and representative western blots shown. Statistical
significance was performed using a one-way analysis of variance
(ANOVA) followed by Tukey’s post-hoc test, or a paired Student’s t-
test as appropriate (Prism-6® software, GraphPad, San Diego, CA,
USA) and this is specified in figure legends.3. Results
3.1. Adenosine receptor (AR) stimulation enhances NR4A expression
in THP-1 cells
Initially, we established NR4A1-3 gene expression in THP-1 cells
stimulated with adenosine or NECA. There was a concentration-
dependent induction of NR4A1-3 expression in cells treated with
adenosine (1, 10 and 50 mM), and a significant increase with NECA
(20 mM) for 2 hs (Fig. 1a and b). Throughout the rest of the study
NECA (20 mM) was primarily used during 2 h exposures (unless
stated otherwise), as it is more stable than adenosine and gave a
similar pattern of NR4A expression in THP-1 cells. Taken together,
adenosine and NECA enhance NR4A expression in THP-1 cells.
Fig. 3. Ubiquitin and proteasome pathways are involved in adenosine receptor driven NR4A expression. (a) THP-1 cells were exposed to NECA (20 mM), BAY11-7802 (10 mM)
and MG-132 (10 mM) alone for 2hr or NECA (20 mM) for 2 hs following 30 min pre-treatment with BAY11-7082 (10 mM) or MG132 (10 mM), followed by RNA isolation (n ¼ 3). (b)
THP-1 cells were exposed to NECA (20 mM) and BAY 11e7802 (10 mM) alone for 4 hs or NECA (20 mM) for 4 h s following 30 min pre-treatment with BAY 11e7082 (10 mM), followed
by whole cell lysis (n ¼ 2). Analysis: (a) Following RNA isolation, qRT-PCR was performed for targets genes NR4A1-3 and housekeeping gene GAPDH. (b) Following whole cell lysis
Western blot analysis was performed for NR4A2 and the housekeeping protein TATA-binding-protein (TBP). For statistical analysis, a one-way ANOVA with a Tukeys post-hoc test
was used. ***p < 0.001 treatments compared to untreated control (Un). # # #p < 0.001 specific treatments compared shown using a bar attachment.
H.E. Giffney, E.P. Cummins, E.P. Murphy et al. Biochemical and Biophysical Research Communications 555 (2021) 19e253.2. Protein kinase D is involved in AR-mediated NR4A expression in
THP-1 cells
Next, we examined kinases known to act downstream of AR
stimulation. Fig. 2a and b shows pre-treatment of THP-1 cells for
30 min with the PKA inhibitor, H-89 (100 nM) (IC50-135 nM), fol-
lowed by 2 hs with NECA or a pan-PKC inhibitor, GO6983 (100 nM)
(IC50 ¼ 7, 7, 6, 10, 60 and 20000 nM for PKCa, PKCb, PKCg, PKCd,
PKCz and PKCm (PKD) respectively) did not reduce NECA-enhanced
NR4A1-3 expression in THP-1 cells.
To further explore PKC signalling THP-1 cells were pre-treated
for 30 min with phorbyl mysterate acetate (PMA) (32 nM) (EC50-
14 nM), a known PKC activator, can enhance NR4A1-3 expression
alone (2 hs incubation) and has a significant synergistic effect when
combined with NECA (Fig. 2b). On further analysis, we demonstrate
that PMA, in addition to PKC activation, activates PKD (also known
as PKCm). Following this, we used a specific inhibitor of PKD, CID-
755673 (83 and 166 nM) (IC50: 0.182, 0.280, 0.227, >10 mM at
PKD1, PKD2, PKD3, PKC respectively), on cells 30 min prior to
stimulation with NECA in order to establish if PKD was involved.
CID-755673 at both concentrations attenuated the significant in-
duction of NR4A2-3 expression by NECA (Fig. 2c). In contrast, CID-
755673 pre-treatment did not alter NECA-enhanced NR4A1
expression (Fig. 2c). Taken together, PKD activity is required for AR-
stimulated NR4A2 and NR4A3 gene regulation with no involvement
in AR-mediated NR4A1 expression in THP-1 cells.223.3. NF-kB pathway does not play a role in AR-induced NR4A
expression in THP-1 cells
We next investigated which transcription factor(s) downstream
of PKD were responsible for the enhanced NR4A gene expression
observed in THP-1 cells following AR stimulation. The two main
transcriptional regulators upstream of NR4A genes are CREB and
NF-kB. Moreover, PKD plays roles in activating both CREB and NF-
kB [19e24]. During AR stimulation, when CREB is involved, it is
established this is typically a PKA-mediated event [3,6]. Since we
have already shown in inhibitor studies that PKA is not involved in
AR-driven NR4A expression in THP-1 cells, CREB is also unlikely to
play a role (Fig. 2a). Therefore, we set out to examine the role, if any,
of NF-kB in this pathway.
The combination of inhibitors, BAY11-7082 and MG132, are
useful tools to investigate a putative role for NF-kB within biolog-
ical pathways. These inhibitors interfere with ubiquitin and pro-
teasome pathways respectively, which are essential for NF-kB
activation [25e28]. Pre-treatment (30 min s) separately with
BAY11-7082 (10 mM) (IC50: 10 mM for E2 ubiquitin (Ub) conjugating
enzyme) and MG132 (10 mM) (IC50: 100 nM for proteasome and
1.2 mM for calpain) inhibited NECA-induced NR4A1 and NR4A3 gene
expression. While modest effects of both inhibitors on NECA-
induced NR4A2 gene expression in THP-1 cells were measured
(Fig. 3a), BAY11-7082 (10 mM) inhibits NECA-induced NR4A2 pro-
tein expression in THP-1 cells over 4 hs (Fig. 3b).
Fig. 4. NF-kB and its specific family members IKKa and IKKb are not involved in adenosine receptor stimulated NR4A expression. (a) THP-1 cells were transfected with an
IkBa plasmid and its backbone (BB) control plasmid for 48 hs followed by RNA isolation. (b) THP-1 cells were transfected with an IkBa plasmid and a backbone (BB) control plasmid
for 48 hs followed by treatment with NECA (20 mM) for 2 hs, followed by RNA isolation (n ¼ 4). (b) Wild type (WT) and IKKa/b knockout (IKKa/b/) mouse embryonic fibroblast
(MEF) cells were exposed to (NECA (20 mM) for 2 hs followed by RNA isolation (n ¼ 3). (c) WT and IKKa/b/ MEF cells were exposed to LPS (1 mg/mL) for 2 h s followed by RNA
isolation. Analysis: (a,b,c) Following RNA isolation, qRT-PCR was performed for targets genes IkBa, TNFa, MCP-1, NR4A1-3, TNFa and housekeeping gene GADPH. For statistical
analysis of (a,b) a paired T-test was used to compare against BB untreated, and (c) a one-way ANOVA with a Tukeys Post-hoc test was used. *p < 0.05, **p < 0.01, ***p < 0.001,
treatments compared to untreated BB control or untreated control (Un). NS¼Not significant, specific treatments shown using a bar attachment.
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utilised to confirm the role of NF-kB in this pathway. We overex-
pressed IkBa, an endogenous inhibitor of NF-kB activation, in THP-
1 cells. Following transient transfection, we examined levels of IkBa
in cells and also that of two established NF-kB target genes, TNFa
and MCP-1. Increased IkBa mRNA expression was detectable in
THP-1 transfected for 48 hs with the IkBa plasmid compared to
backbone (BB) control (Fig. 4a). Furthermore, we observed signifi-
cant attenuation of the endogenous expression of TNFa and MCP-1
following transient transfectionwith the IkBa plasmid compared to
the BB control (Fig. 4a). This indicates an appropriate transfection
efficiency, with IkBa functionally inhibiting the NF-kB pathway.
Following this, we treated the IkBa expressing THP-1 cells with
NECA and found that overexpression of IkBa does not prevent AR-
induced expression of NR4A3. As shown in Fig. 4b, the most highly
AR-induced NR4A family member, NR4A3, both basal and NECA-
induced mRNA levels remained unchanged with co-expression of
IkBa. This suggests that the inhibitors, namely BAY11-7082 and
MG-132, are altering AR-stimulated NR4A expression independent
of the NF-kB pathway downstream of IkBa.
BAY11-7082 can modify the IKK complex, which can function
independently of NF-kB [25,29,30]. Additionally, IKKb itself can be
activated by PKD [19,29,30]. Therefore, we tested mouse embryonic
fibroblast (MEF) cells lacking both IKKa and IKKb (IKKa/b/-) to
further examine the role of IKK. While we did observe some basal
level differences in NR4A gene expression in WT versus IKKa/b/-
cells, no attenuation of NECA-induced NR4A genes was observed in23the cells lacking IKKa/b/- (Fig. 4c). This data reinforces the
conclusion that the NF-kB family is not involved in AR-stimulated
NR4A gene expression.
4. Discussion
Studies have demonstrated that adenosine receptor activation
can enhance the expression of NR4A1-3 genes, leading to attenua-
tion of hyper-inflammatory responses in distinct cell types
[8e11,13]. However, the signalling factors downstream of AR-
stimulation that lead to enhanced expression of NR4A genes in
myeloid cells is unknown and were the primary focus of this study.
Following establishing that adenosine and its stable analogue
NECA can enhance NR4A expression in THP-1 cells, we set out to
examine the kinase(s) involved downstream of AR stimulation
leading to NR4A expression. Multiple kinases such as PKA, PKC and
PKD are known to act downstream of AR stimulation, and they have
also been shown to regulate NR4A gene expression in other con-
texts [16,31,32]. The PKA inhibitor, H-89, did not inhibit AR-
stimulated NR4A expression in the THP-1 cells, which has also
been reported in mast cells [10], whereas adenosine-induced NR4A
expression has been shown to be PKA-dependent in neutrophils
[13].
Using the pan-PKC inhibitor, GO6983, we provide evidence
showing that PKC is not likely to be involved in AR stimulated NR4A
expression in THP-1 cells, whilst it has been shown that PKC was
involved in AR-stimulated NR4A expression in mast cells [10].
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PKC activator, alone enhanced NR4A expression and potentiated its
expression when combined with NECA, a result that initially cast
doubt on the PKC inhibition data. However, PMA can also activate
PKD at concentrations used in this study [32]. Additionally, PKD1
and PKD2 have been shown to be essential for PMA and gastrin-
induced expression of NR4A1 in DO11.10 and AGS-B cells respec-
tively [32,33]. Our results provide evidence that PKD inhibition
using CID-75573, which inhibits all three PKD isoforms at con-
centrations used, blocks the capacity of AR stimulation to enhance
NR4A expression in THP-1 cells. This data supports a role for PKD
activation in driving AR-mediated NR4A expression (Which is in-
dependent of PKC, a phenomena that has been previously reported
[34e36]).
Next, we set out to examine which transcription factor was
involved downstream of this AR-PKD pathway identified leading to
enhanced NR4A gene expression, with a focus on NFkB, a principal
regulator ofNR4As in myeloid cells [5]. Pharmacological approaches
using BAY 11e7082 and MG-132, inhibitors of ubiquitin and pro-
teasome pathways essential for NF-kB activation, indicated a
possible role for NF-kB as a regulator of NR4A genes downstream of
AR-stimulation [25]. Overexpressed of IkBa (an endogenous in-
hibitor of NF-kB) in THP-1 cells significantly attenuated TNFa and
MCP-1 expression with no effects on AR-induced NR4A expression.
At this point, we focused on the fact that BAY11-7082 could still
inhibit AR-driven NR4A expression, but not acting through NF-kB.
BAY11-7082 can affect ubiquitin systems, which in turn lead to the
inactivation of the IKK complex [25]. IKK itself can have multiple
roles independent of NF-kB, for example by modulating cellular
regulators including p53, IRF7, FOXO3a, LC3 and, as such, BAY11-
7082 could highlight these independent roles [29,30]. Further-
more, it has been shown that PKD can phosphorylate IKKb pro-
moting its activation [19]. Therefore, here we used MEFs that lack
both IKKa and IKKb (IKKa/b/-) and results indicate that IKKs do not
play a role in AR-PKD-driven NR4A expression in our cell system.
In summary, this study develops our understanding on the
mechanisms involved in AR-mediated NR4A expression in myeloid
cells. AR stimulation by adenosine-based agonists modulate NR4A
receptor expression in THP-1 myeloid cells, and our studies identify
a central role for PKD in mediating this control. Further in-
vestigations exclude NF-kB activity and specific family members,
IKKa/b, in AR-PKD-stimulated NR4A pathway, while pharmaco-
logical evidence shows ubiquitin and proteasome pathways are
involved. Thus, the results presented here contribute mechanistic
insight into how AR signalling modulates the expression of the
NR4A receptors, key regulators of inflammatory responses in
myeloid cells.Declaration of competing interest
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